Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06408350 · ClinicalTrials.gov registry record · NA

Optimal Intervention to Full Viral Suppression: Text Me, Alexis!

A NA study, sponsored by Friends Research Institute.

Terminated
Registry status
NA
Development phase
71
Enrollment target

NCT06408350 is a NA study that was terminated before completion, run by Friends Research Institute. The registered enrollment target is 71 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06408350, a NA study, was terminated before completion, sponsored by Friends Research Institute.

TERMINATED
Registry status
NA
Development phase
71 participants
Enrollment target

Study Summary

Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal and most cost-effective intervention for advancing trans women living with HIV to full viral suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone, SMS (text messaging) alone, or PHN+SMS. Participants in the PHN alone and PHN+SMS arms will receive unlimited navigation sessions over 3 months. Participants in the SMS alone and PHN+SMS arms will receive 3 daily theory-based text messages for 90 days for a total of 270 unique scripted messages.

Interventions

  • BEHAVIORAL Text Me, Alexis!

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2024-04-11
Est. Completion 2025-03-19
Phase NA

Sponsor

Friends Research Institute

41 total trials

What the Registry Record Tells You About NCT06408350

The ClinicalTrials.gov registry entry for NCT06408350 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Text Me, Alexis! is the first listed.

NCT06408350 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06408350 about?

NCT06408350 is a clinical study titled "Optimal Intervention to Full Viral Suppression: Text Me, Alexis!". Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal and most cost-effective intervention for advancing trans women living with HIV to full viral suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone, SMS (text messaging) alo...

What is the current status of trial NCT06408350?

This trial is currently terminated. It is a NA study. The enrollment target is 71 participants. The study started on 2024-04-11. Estimated completion is 2025-03-19.

What interventions are being tested in trial NCT06408350?

The interventions under investigation include: Text Me, Alexis! (BEHAVIORAL).

Who is sponsoring clinical trial NCT06408350?

This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.